Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellstat Vaccines is a private U.S. vaccine biotechnology company within the Wellstat group that focused on synthetic and semisynthetic conjugate carbohydrate vaccines for infectious diseases. Publicly available company-profile sources describe programs against meningococcal disease, Haemophilus influenzae type b, Group A and B streptococcal infections, pneumococcal disease, candidiasis, and aspergillosis. Patent activity also indicates work in fungal immunology, including antibodies directed to fungal cell wall polysaccharides. The company appears to have operated from Gaithersburg, Maryland and was part of the broader Wellstat Therapeutics organization. Recent business databases characterize Wellstat Vaccines as no longer active, and no evidence of a current operating corporate presence or commercial products was identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellstat Vaccines.